Evidence map›Paper›PMID 25855735›Full record

ArticleJournal of virology2015

Interaction between Shadoo and PrP Affects the PrP-Folding Pathway.

Danica Ciric, Charles-Adrien Richard, Mohammed Moudjou, Jérôme Chapuis, Pierre Sibille, Nathalie Daude, David Westaway, Miguel Adrover, Vincent Béringue, Davy Martin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. The First Genetic Characterization of theAnimals : an open access journal from MDPI · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The First Report of Genetic Polymorphisms of the EquineAnimals : an open access journal from MDPI · 2021
    Article
  10. Article
  11. Article
  12. Causative Links between Protein Aggregation and Oxidative Stress: A Review.International journal of molecular sciences · 2019
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Danica CiricNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
Charles-Adrien RichardNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
Mohammed MoudjouNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
Jérôme ChapuisNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
Pierre SibilleNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
Nathalie DaudeUniversity of Alberta, Centre for Prion and Protein Folding Diseases, Research in Neurodegenerative Diseases, Edmonton, AB, Canada.
David WestawayUniversity of Alberta, Centre for Prion and Protein Folding Diseases, Research in Neurodegenerative Diseases, Edmonton, AB, Canada.
Miguel AdroverInstitut Universitari d'Investigació en Ciències de la Salut (IUNICS), Departament de Química, Universitat de les Illes Balears, Palma de Mallorca, Spain.
Vincent BéringueNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France.
Davy MartinNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France davy.martin@jouy.inra.fr human.rezaei@jouy.inra.fr.
Human RezaeiNational Institute for Agricultural Research (INRA), Pathological Macro-Assemblies and Prion Pathology Group (MAP), UR892, Virologie Immunologie Moléculaires, Jouy-en-Josas, France davy.martin@jouy.inra.fr human.rezaei@jouy.inra.fr.
Virologie et Immunologie Moléculaires · FRUniversity of Alberta · CAServei de Salut de les Illes Balears · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledPrion diseases are characterized by conformational changes of a cellular prion protein (PrP(C)) into a β-sheet-enriched and aggregated conformer (PrP(Sc)). Shadoo (Sho), a member of the prion protein family, is expressed in the central nervous system (CNS) and is highly conserved among vertebrates. On the basis of histoanatomical colocalization and sequence similarities, it is suspected that Sho and PrP may be functionally related. The downregulation of Sho expression during prion pathology and the direct interaction between Sho and PrP, as revealed by two-hybrid analysis, suggest a relationship between Sho and prion replication. Using biochemical and biophysical approaches, we demonstrate that Sho forms a 1:1 complex with full-length PrP with a dissociation constant in the micromolar range, and this interaction consequently modifies the PrP-folding pathway. Using a truncated PrP that mimics the C-terminal C1 fragment, an allosteric binding behavior with a Hill number of 4 was observed, suggesting that at least a tetramerization state occurs. A cell-based prion titration assay performed with different concentrations of Sho revealed an increase in the PrP(Sc) conversion rate in the presence of Sho. Collectively, our observations suggest that Sho can affect the prion replication process by (i) acting as a holdase and (ii) interfering with the dominant-negative inhibitor effect of the C1 fragment. IMPORTANCE: Since the inception of the prion theory, the search for a cofactor involved in the conversion process has been an active field of research. Although the PrP interactome presents a broad landscape, candidates corresponding to specific criteria for cofactors are currently missing. Here, we describe for the first time that Sho can affect PrP structural dynamics and therefore increase the prion conversion rate. A biochemical characterization of Sho-PrP indicates that Sho acts as an ATP-independent holdase.

Indexed as

Protein FoldingAnimalsGPI-Linked ProteinsMiceNerve Tissue ProteinsPrionsProtein BindingProtein MultimerizationTwo-Hybrid System TechniquesGPI-Linked ProteinsNerve Tissue ProteinsPrionsSprn protein, mouse

Identifiers

PMID25855735
PMCPMC4474288
OpenAlexW2093302732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.